Clinical trial
Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis Patients in Turkey
NCT05441020 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis Patients in Turkey
- Lead sponsor
- Fresenius Medical Care Deutschland GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 18, 2022
- Completion date
- March 20, 2023
- Enrollment
- 173 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, renal failure